Medicare Enrolled
Dr. Mario Lammoglia, M.D.
Cardiovascular Disease · College Station, TX
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lammoglia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lammoglia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lammoglia
Dr. Mario Lammoglia is a cardiovascular disease specialist in College Station, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lammoglia performed 4,927 Medicare services across 3,288 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lammoglia received a total of $18,062 from 56 pharmaceutical and/or device companies across 760 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lammoglia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in TX
$18,062 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,927
Medicare services
Top 17% in TX for cardiovascular disease
3,288
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~259 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 666 | $82 | $133 |
| Electrocardiogram (EKG), 12-lead | 613 | $10 | $20 |
| Regadenoson injection (Lexiscan) for heart stress test | 492 | $40 | $66 |
| Injection, dipyridamole, per 10 mg | 458 | $3 | $5 |
| Remote pacemaker/defibrillator monitoring, 90 days | 240 | $14 | $30 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 226 | $54 | $81 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 215 | $224 | $514 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 212 | $1,073 | $1,359 |
| Echocardiogram, transthoracic | 195 | $141 | $201 |
| Remote pacemaker monitoring, 90 days | 169 | $20 | $40 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 159 | $25 | $46 |
| Programming of dual lead pacemaker system | 148 | $27 | $53 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 116 | $17 | $30 |
| Evaluation of implantable heart and blood vessel monitoring system | 113 | $15 | $70 |
| New patient office visit (45-59 min) | 74 | $114 | $167 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 71 | $26 | $60 |
| Ultrasound of both sides of head and neck blood flow | 67 | $144 | $191 |
| Hospital follow-up visit, moderate complexity | 61 | $62 | $78 |
| Injection, aminophyllin, up to 250 mg | 58 | $4 | $5 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 53 | $20 | $31 |
| Initial hospital admission, high complexity | 51 | $136 | $194 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 49 | $181 | $250 |
| Office visit, established patient (20-29 min) | 48 | $66 | $90 |
| Programming of multiple lead implantable defibrillator system | 42 | $40 | $74 |
| Office visit, established patient, complex (40-54 min) | 38 | $128 | $177 |
| Programming of dual lead implantable defibrillator system | 36 | $38 | $73 |
| Programming of multiple lead pacemaker system | 25 | $30 | $70 |
| Programming of cardiac rhythm monitor system | 24 | $22 | $90 |
| New patient office visit, complex (60-74 min) | 24 | $159 | $216 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 22 | $14 | $20 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 21 | $132 | $187 |
| External shock to heart to regulate heart beat | 19 | $106 | $3,748 |
| Cardiac catheterization | 19 | $170 | $313 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 18 | $207 | $265 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 17 | $6 | $10 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 17 | $18 | $30 |
| Ultrasound of leg arteries or artery grafts | 15 | $182 | $241 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $72 | $224 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $397 | $979 |
| Insertion of heart rhythm monitor under skin | 11 | $3,366 | $4,940 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
19.4% high complexity
32.1% medium
48.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,062
Total received (2018-2024)
Avg $2,580/year across 7 years
Top 20% in TX for cardiovascular disease
56
Companies
760
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,062 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,883
2023
$2,235
2022
$2,040
2021
$2,537
2020
$1,155
2019
$4,615
2018
$2,597
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$7,490
Amgen Inc.
$1,367
Endologix, Inc.
$1,340
E.R. Squibb & Sons, L.L.C.
$784
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$737
Novartis Pharmaceuticals Corporation
$671
PFIZER INC.
$564
Amarin Pharma Inc.
$501
Janssen Pharmaceuticals, Inc
$415
AstraZeneca Pharmaceuticals LP
$377
Actelion Pharmaceuticals US, Inc.
$248
BOSTON SCIENTIFIC CORPORATION
$211
Boston Scientific Corporation
$178
Endologix LLC
$173
Novo Nordisk Inc
$171
Impulse Dynamics (USA) Inc.
$165
AngioDynamics, Inc.
$160
Tactile Systems Technology Inc
$154
Kowa Pharmaceuticals America, Inc.
$153
Merck Sharp & Dohme LLC
$147
Chiesi USA, Inc.
$132
ABIOMED
$128
Gilead Sciences, Inc.
$121
Terumo Medical Corporation
$117
W. L. Gore & Associates, Inc.
$114
Cardinal Health 200, LLC
$110
Kiniksa Pharmaceuticals International, plc
$110
ARBOR PHARMACEUTICALS, INC.
$101
Esperion Therapeutics, Inc.
$101
Daiichi Sankyo Inc.
$82
Alnylam Pharmaceuticals Inc.
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$74
Kiniksa Pharmaceuticals, Ltd.
$74
Lundbeck LLC
$69
SANOFI-AVENTIS U.S. LLC
$67
Edwards Lifesciences Corporation
$63
CARDIVA MEDICAL, INC.
$60
Cardinal Health 200 LLC
$57
Kestra Medical Technology Services, Inc.
$38
Bayer HealthCare Pharmaceuticals Inc.
$38
CORDIS US CORP.
$31
Cook Medical LLC
$31
Astellas Pharma US Inc
$23
Medtronic, Inc.
$23
Cardiovascular Systems Inc.
$23
VivaQuant Inc, dba Rhythm Express
$22
Endologix, LLC
$21
BIOTRONIK INC.
$21
Philips Electronics North America Corporation
$20
CHIESI USA, INC.
$17
ZOLL Circulation Inc
$16
Regeneron Healthcare Solutions, Inc.
$15
Relypsa, Inc.
$14
Medtronic Vascular, Inc.
$14
MEDICOMP INC
$13
Arbor Pharmaceuticals, Inc.
$12
Top 3 companies account for 56.5% of total payments
Associated products mentioned in payments ›
(6554) Peripheral Vascular Undivided · ACCENT · AFX · AFX2 Bifurcated Endograft System · AGILIS · AGILIS HISPRO · ALLURE QUADRA · AMBULATORY CARDIAC MONITOR · ANGIOGUARD · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Ablation Therapy Hardware · Accent Pacemaker · Adempas · Allure Quadra RF CRT Pacemaker · AngioSeal · Arcalyst · Assure WCD · Assurity Pacemaker · BELSOMRA · BRILINTA · CAMZYOS · CARDIOMEMS · CHANTIX · CLEVIPREX 50MG/100ML · CONFIRM RX · COOK · CRT-Ps · CardioMEMS HF System · Confirm Rx · Corlanor · ELIQUIS · ELUVIA · ENSITE · ENSITE PRECISION · ENTRESTO · EXCLUDER AAA Endoprosthesis · EXCLUDER Conformable AAA Endoprosthesis with Active Control · Edarbi · Edarbyclor · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FARXIGA · FLEXITOUCH · Flexitouch Plus · Fortify Assura · GALLANT · GENERAL STENTS · GENERAL - STENTS · GORE EXCLUDER AAA Endoprosthesis · GUIDEZILLA · GlideWire · HORNET · HeartMate 3 Left Ventricular Assist Device · HeartWare HVAD · INFINITI Diagnostic Catheter · INJECTAFER · ISOFLEX · Impella · JARDIANCE · JOT DX · KENGREAL · LEQVIO · LEXISCAN · LifeVest · Livalo · MERLIN@HOME · MULTAQ · Merlin Connectivity and Remote · Misago · Mitra Clip system · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPTOWIRE · Optimizer · Ovation · Ozempic · PCI Optimization · PRADAXA · PRALUENT · Pacemakers · Peel-Away Standard Introducer · Peripheral Orbital Atherectomy System · PressureWire FFR · QUADRA ALLURE MP · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RAIN SheathTM · ROTABLATOR · ROTALINK · Repatha · Resolute · Rhythm Express · Rybelsus · S.M.A.R.T. CONTROL Self-Expanding Nitinol Stent · S.M.A.R.T. Flex Stent · S.M.A.R.T. Self-Expanding Nitinol Stent · SABER · SYNERGY · Saxenda · TENDRIL · TR Band · TherOx DS2 Console · UPTRAVI · VERQUVO · Vascepa · Vascular Closure Device · Veltassa · WALLSTENT · WATCHMAN Access System · WOLVERINE · WORKMATE CLARIS · XARELTO · Xience Sierra Coronary Stent · Xience V coronary stent system
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $367 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
16
Per 100K population
6.7
County median income
$58,388
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER- COLLEGE STATI
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lammoglia is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 17% in TX), with low-engagement industry engagement in the top 20% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lammoglia experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lammoglia performed 666 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lammoglia receive payments from pharmaceutical companies?
Yes. Dr. Lammoglia received a total of $18,062 from 56 companies across 760 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lammoglia's costs compare to other cardiologists in College Station?
Dr. Lammoglia's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lammoglia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in College Station
Browse cardiologists in College Station ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Endologix, Inc. Payments to Doctors
See all physicians who received payments from Endologix, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology